
Company Description
A privately held Swiss biopharmaceutical company.
Redvax is a spin-off from Redbiotec AG, a privately held Swiss biopharmaceutical company, based in Zurich-Schlieren. Redvax is a preclinical stage company. The company develops multi-component virus-like particles (VLPs) and other protein assemblies for vaccine development in the field of CMV and a further undisclosed field.
-
Manufacturer:
Science and Engineering -
Company Website:
-
Company E-mail:
-
Company Address:
Wagistrasse 23SchlierenSwitzerland -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits